More Molecular Diagnostics

With its purchase of the genetic testing company Navigenics, Life Technologies is building "its molecular diagnostics business through internal development, partnerships, and select acquisitions," the company says in a press release. Life Tech adds that Navigenics will bring infrastructure — including a CLIA lab — and expertise to Life Tech's molecular diagnostics business.

Ronnie Andrews, president of medical sciences at Life Tech, said at a press conference held at the American Association for Clinical Chemistry's annual meeting that this acquisition is the first of several that will "allow us to immediately address unmet medical needs," as the Sample's sister publication GenomeWeb Daily News reports. GWDN has more on Life Tech's announcement and plans here.